InvestorNewsBreaks – Med-X Inc. (Reserved NASDAQ: MXRX) Advances Nature-Cide Natural Pest-Control Platform Ahead of Planned Public-Market Debut

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Med-X (Reserved NASDAQ: MXRX), a privately held health and wellness company preparing for a planned Nasdaq listing, is advancing its Nature-Cide brand as the primary growth platform within its portfolio. Nature-Cide develops and commercializes natural pesticide and pest-management products for professional operators and consumers, with applications spanning residential pest control, agriculture, commercial facilities, municipalities and other markets. Med-X also owns Thermal-Aid, a line of reusable heating and cooling pain-relief products, and Malibu Brands, which focuses on essential oil-based wellness solutions.

Nature-Cide has expanded from its origins in localized pest-management applications into a portfolio of indoor, outdoor, dust and granular products, with Med-X emphasizing formulation science, testing and adoption by professional pest-control operators. The company recently obtained OMRI certification for key products, potentially broadening opportunities in organic food production, livestock operations and other agricultural applications, while management is targeting expanded commercial adoption, production capacity, acquisitions and research and development as Med-X moves toward its anticipated public-market debut.

To view the Med-X investor presentation, visit https://ibn.fm/Ai648

About Med-X, Inc.

Med-X, Inc. (NASDAQ: MXRX) is a leading innovator of biological pest control solutions addressing both consumer and professional markets globally. Nature-Cide – the Company’s flagship product line – is a safer, all-natural alternative to conventional chemical products, formulated to kill or repel a wide variety of pests. Med-X’s comprehensive go-to-market strategy includes leveraging strategic partnerships alongside an integrated e-commerce, brick and mortar and on-site services presence in key markets.

For more information, please visit www.medx-rx.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  253.71
-3.07 (-1.20%)
AAPL  334.19
+1.93 (0.58%)
AMD  497.61
-18.52 (-3.59%)
BAC  59.24
-3.45 (-5.50%)
GOOG  343.79
+8.34 (2.49%)
META  665.48
+17.45 (2.69%)
MSFT  505.88
+10.25 (2.07%)
NVDA  212.52
-5.77 (-2.64%)
ORCL  143.72
-6.56 (-4.37%)
TSLA  360.72
-4.72 (-1.29%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.